IKT logo

Inhibikase Therapeutics, Inc. (IKT)

Profile

Full Name

Inhibikase Therapeutics, Inc.

Ticker

NASDAQ: IKT

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

December 23, 2020

Indexes

Not included

Website

https://www.inhibikase.com

Employees

15

Key Details

Price

$1.80(-2.17%)

Market cap

$134.13M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(-100.00% YoY)

Annual EPS

-$1.16(+67.51% YoY)

PE ratio

-

Next earnings date

Nov 13, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $1.80
    IKT price is $1.80

    30-Day Relative Volume

    0.57
    IKT 30-day relative volume is 0.57

    Price Performance

    Price Most recent change

    -2.17%
    IKT price was down -2.17% on Aug 29, 2025

    Price YTD change

    -44.62%
    IKT price is down -44.62% since January 1st

    Price 1-year change

    +29.78%
    IKT price is up +29.78% year-on-year

    Price 3-year change

    -65.99%
    IKT price is down -65.99% over the past 3 years

    Price Range

    Price All-time high

    $70.80
    IKT price is currently -97.46% below its historical high of $70.80

    Price 3-year low

    $0.79
    IKT price is currently +127.85% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $134.13M
    IKT market capitalization is $134.13 million

    Market cap 3-year change

    +502.83%
    IKT market capitalization is up +502.83% over the past 3 years

    Market cap All-time high

    $266.75M
    IKT market capitalization is currently -49.72% below its historical high of $266.75 million

    Market cap sector rank

    45.61%
    IKT market capitalization is higher than 45.61% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +898.33%
    IKT shares outstanding is up +898.33% year-on-year

    Shares Outstanding 3-Year Change

    +1672.31%
    IKT shares outstanding is up +1672.31% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.36
    IKT beta is 1.36

    200-day SMA

    $2.24
    IKT price is currently -19.78% below its 200-day simple moving average

    50-day SMA

    $1.77
    IKT price is currently +1.60% above its 50-day simple moving average

    RSI

    52.47
    IKT 14-day relative strength index is 52.47

    Volume

    0.57
    IKT 30-day relative volume is 0.57

    ATR

    $0.14
    IKT average true range is $0.14

    10-day Historical Volatility

    83.37%
    IKT 10-day historical volatility is 83.37%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    IKT annual revenue is $0.00

    Revenue Analysts estimate

    -
    IKT annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -100%
    IKT annual revenue is down -100% year-on-year

    Revenue Sector rank

    28.67%
    IKT annual revenue is higher than 28.67% of companies in Healthcare sector

    EPS

    EPS

    -$1.16
    IKT annual earnings per share is -$1.16

    EPS Analysts estimate

    -$0.51
    IKT annual earnings per share is currently +127.45% higher than the consensus analysts' forecast

    EPS 1-year change

    +67.51%
    IKT annual earnings per share is up +67.51% year-on-year

    EPS Sector rank

    48.84%
    IKT annual earnings per share is higher than 48.84% of companies in Healthcare sector

    Profit

    Gross profit

    -$26.30K
    IKT annual gross profit is -$26.30 thousand

    Gross margin

    -
    IKT annual gross profit margin value is unknown

    Operating profit

    -$28.59M
    IKT annual operating income is -$28.59 million

    Operating margin

    -
    IKT annual operating profit margin value is unknown

    Net income

    -$27.52M
    IKT annual net profit is -$27.52 million

    Net margin

    -
    IKT annual net profit margin value is unknown

    Expenses

    Total expenses

    $27.52M
    IKT annual total expenses is $27.52 million

    Operating expenses

    $28.56M
    IKT annual total operating expenses is $28.56 million

    Cost of goods sold

    $26.30K
    IKT annual cost of goods sold is $26.30 thousand

    Selling, general & administrative expenses

    $0.00
    IKT annual SGA is $0.00

    Depreciation and amortization

    $26.30K
    IKT annual depreciation & amortization is $26.30 thousand

    Interest expense

    $0.00
    IKT annual interest expense is $0.00

    Income tax

    $0.00
    IKT annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$28.59M
    IKT annual earnings before interest & taxes is -$28.59 million

    EBITDA

    -$28.56M
    IKT annual EBITDA is -$28.56 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $98.60M
    IKT annual total assets is $98.60 million

    Non current assets

    $148.50K
    IKT annual long term assets is $148.50 thousand

    Current assets

    $98.45M
    IKT annual total current assets is $98.45 million

    Cash and cash equivalents

    $97.54M
    IKT annual cash & cash equivalents is $97.54 million

    Accounts receivable

    -
    IKT annual accounts receivable value is unknown

    Inventory

    $0.00
    IKT annual inventory is $0.00

    Liabilities

    Total liabilities

    $3.73M
    IKT annual total liabilities is $3.73 million

    Long term liabilities

    $0.00
    IKT annual total long term liabilities is $0.00

    Current liabilities

    $3.73M
    IKT annual total current liabilities is $3.73 million

    Accounts payable

    $943.00K
    IKT annual accounts payable is $943.00 thousand

    Debt

    Total debt

    $110.50K
    IKT annual total debt is $110.50 thousand

    Total debt 1-year change

    -82.23%
    IKT annual total debt is down -82.23% year-on-year

    Long term debt

    $0.00
    IKT annual long term debt is $0.00

    Short term debt

    $110.50K
    IKT annual short term debt is $110.50 thousand

    Equity & Capital

    Shareholders equity

    $94.87M
    IKT annual stockholders equity is $94.87 million

    Book value

    $94.87M
    IKT annual book value is $94.87 million

    Retained earnings

    -$94.42M
    IKT annual retained earnings is -$94.42 million

    Working capital

    $94.72M
    IKT annual working capital is $94.72 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$19.15M
    IKT annual cash flow from operations is -$19.15 million

    Cash from operations 1-year change

    -5.88%
    IKT annual cash flow from operations is down -5.88% year-on-year

    Cash from investing

    -$37.00M
    IKT annual cash flow from investing activities is -$37.00 million

    Cash from investing 1-year change

    -417.45%
    IKT annual cash flow from investing activities is down -417.45% year-on-year

    Cash from financing

    $103.48M
    IKT annual cash flow from financing activities is $103.48 million

    Cash from financing 1-year change

    +1131.14%
    IKT annual cash flow from financing activities is up +1131.14% year-on-year

    CAPEX

    CAPEX

    $0.00
    IKT annual capital expenditures is $0.00

    CAPEX 1-year change

    -100%
    IKT annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free cash flow

    -$19.15M
    IKT annual free cash flow is -$19.15 million

    Free cash flow 1-year change

    -5.8%
    IKT annual free cash flow is down -5.8% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    IKT annual gross profit margin value is unknown

    Operating margin

    -
    IKT annual operating profit margin value is unknown

    Net margin

    -
    IKT annual net profit margin value is unknown

    ROA & ROE

    ROA

    -48.66%
    IKT annual return on assets is -48.66%

    ROE

    -52.00%
    IKT annual return on equity is -52.00%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    IKT price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    IKT price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.68
    IKT price to book ratio is 1.68

    PB ratio Sector rank

    49.46%
    IKT price to book ratio is higher than 49.46% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    IKT price to sales ratio value is unknown

    PS ratio Sector rank

    -
    IKT price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $46.50M
    IKT enterprise value is $46.50 million

    Enterprise value Sector rank

    39.28%
    IKT enterprise value is higher than 39.28% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.02
    IKT EV/EBITDA is -1.02

    EV/EBITDA Sector rank

    46.33%
    IKT EV/EBITDA is higher than 46.33% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    26.37
    IKT annual current ratio is 26.37

    Quick ratio

    26.37
    IKT annual quick ratio is 26.37

    Leverage

    Debt to equity

    0.00
    IKT annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    IKT annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    IKT piotroski f-score value is unknown

    Altman Z-Score

    20.41
    IKT altman z-score is 20.41

    Analyst ratings

    Recent major analysts updates

    Mar 28, 25 HC Wainwright & Co.
    Neutral
    Feb 12, 25 HC Wainwright & Co.
    Neutral
    Nov 8, 24 Jefferies
    Buy
    Oct 14, 24 HC Wainwright & Co.
    Buy
    Aug 16, 24 HC Wainwright & Co.
    Buy
    May 21, 24 HC Wainwright & Co.
    Buy
    Mar 7, 24 HC Wainwright & Co.
    Buy
    Mar 5, 24 HC Wainwright & Co.
    Buy
    Aug 15, 23 HC Wainwright & Co.
    Buy
    Jun 30, 23 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with IKT included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for Inhibikase Therapeutics, Inc.?
    • Does Inhibikase Therapeutics, Inc. pay dividends?
    • What sector is Inhibikase Therapeutics, Inc. in?
    • What industry is Inhibikase Therapeutics, Inc. in?
    • What country is Inhibikase Therapeutics, Inc. based in?
    • When did Inhibikase Therapeutics, Inc. go public?
    • Is Inhibikase Therapeutics, Inc. in the S&P 500?
    • Is Inhibikase Therapeutics, Inc. in the NASDAQ 100?
    • Is Inhibikase Therapeutics, Inc. in the Dow Jones?
    • When was Inhibikase Therapeutics, Inc.'s last earnings report?
    • When does Inhibikase Therapeutics, Inc. report earnings?

    What is the ticker symbol for Inhibikase Therapeutics, Inc.?

    The ticker symbol for Inhibikase Therapeutics, Inc. is NASDAQ:IKT

    Does Inhibikase Therapeutics, Inc. pay dividends?

    No, Inhibikase Therapeutics, Inc. does not pay dividends

    What sector is Inhibikase Therapeutics, Inc. in?

    Inhibikase Therapeutics, Inc. is in the Healthcare sector

    What industry is Inhibikase Therapeutics, Inc. in?

    Inhibikase Therapeutics, Inc. is in the Biotechnology industry

    What country is Inhibikase Therapeutics, Inc. based in?

    Inhibikase Therapeutics, Inc. is headquartered in United States

    When did Inhibikase Therapeutics, Inc. go public?

    Inhibikase Therapeutics, Inc.'s initial public offering (IPO) was on December 23, 2020

    Is Inhibikase Therapeutics, Inc. in the S&P 500?

    No, Inhibikase Therapeutics, Inc. is not included in the S&P 500 index

    Is Inhibikase Therapeutics, Inc. in the NASDAQ 100?

    No, Inhibikase Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Inhibikase Therapeutics, Inc. in the Dow Jones?

    No, Inhibikase Therapeutics, Inc. is not included in the Dow Jones index

    When was Inhibikase Therapeutics, Inc.'s last earnings report?

    Inhibikase Therapeutics, Inc.'s most recent earnings report was on August 14, 2025

    When does Inhibikase Therapeutics, Inc. report earnings?

    The next expected earnings date for Inhibikase Therapeutics, Inc. is November 13, 2025
    On this page